Renal impairment

4 total trials MedDRA PT

Filter these 4 trials by phase, country, sponsor and more.

Open in Search →

A Phase 1b, Double-blind, Placebo-controlled, Randomised Trial Investigating the Effect of AZD3427 on Renal Perfusion in HFrEF Patients With … Ended

2024-513143-82-00 3 2024-10-15 "Heart failure with reduced ejection fraction"
An Open-label, Single-dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of JNJ-77242113 in Adult Participants Ended

2023-510161-97-00 3 2024-06-19 "Renal Impairment"
A study to test how BI 456906 is taken up in the blood of people with and without kidney problems Ended

2023-508557-13-00 3 2024-05-08 "Renal impairment (mild, moderate and severe)"
A Multiple Dose Pharmacokinetic Study of AMX0035 in Participants with Impaired Renal Function and in Healthy Participants Ended

2023-504393-37-00 3 2023-10-31 "Volunteers with Renal Impairment"

Showing 1–4 of 4 trials